drug therapy

Open Access
Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer
MOTOYUKI SUZUKI, YUKINORI TAKENAKA, TOSHIHIRO KISHIKAWA, YOSHIFUMI YAMAMOTO, ATSUSHI HANAMOTO, YOICHIRO TOMIYAMA, TAKAHITO FUKUSUMI, TAKAHIRO MICHIBA, NORIHIKO TAKEMOTO, SUSUMU NAKAHARA and HIDENORI INOHARA

Anticancer Research April 2021, 41 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.14973
You have access
YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression
TAKESHI MIYAO, HIDEKAZU KOIKE, YOSHITAKA SEKINE, AKIRA OHTSU, DAISUKE OKA and KAZUHIRO SUZUKI

Anticancer Research September 2020, 40 (9) 5091-5095; DOI: https://doi.org/10.21873/anticanres.14512
You have access
YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin
TAKASHI NITTA, HIDEKAZU KOIKE, TAKESHI MIYAO, YOSHIYUKI MIYAZAWA, HARUO KATO, YOSUKE FURUYA, YOSHITAKA SEKINE and KAZUHIRO SUZUKI

Anticancer Research January 2017, 37 (1) 75-80;

Main menu